Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jo Salkeld

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Medicine (London, England)|November 3, 2024
Malaria: Past, present and futureJo Salkeld, Andrew Duncan, Angela M Minassian
Clinical Infection in Practice|August 24, 2021
Compassionate use of REGN-COV2 in the treatment of COVID-19 in a patient with impaired humoral immunityHanna Nguyen, Jo Salkeld, Sangita Agarwal, et al.
Clinical Infection in Practice|June 26, 2023
Prescribing in a pandemic: Electronic prescribing aids to improve non-specialist adherence to COVID-19 guidelinesMarc Woodman, Jo Salkeld, Connor Sharrock, et al.
Geriatrics (Basel, Switzerland)|July 8, 2020
Inter-Relationships between Frailty, Sarcopenia, Undernutrition and Dysphagia in Older People Who Are Admitted to Acute Frailty and Medical Wards: Is There an Older Adult Quartet?David Smithard, Dharinee Hansjee, Darrien Henry, et al.
Frontiers in Immunology|September 8, 2022
Repeat controlled human malaria infection of healthy UK adults with blood-stage <i>Plasmodium falciparum</i>: Safety and parasite growth dynamicsJo Salkeld, Yrene Themistocleous, Jordan R Barrett, et al.
Immunity|June 12, 2026
Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protectionBarnabas G Williams, Jordan R Barrett, Josefin Bartholdson Scott, et al.
The Lancet. Infectious Diseases|December 13, 2024
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in childrenHamtandi M Natama, Jo Salkeld, Athanase Somé, et al.
Science Translational Medicine|July 12, 2023
Vaccination with <i>Plasmodium vivax</i> Duffy-binding protein inhibits parasite growth during controlled human malaria infectionMimi M Hou, Jordan R Barrett, Yrene Themistocleous, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2022
Impact of a blood-stage vaccine on <i>Plasmodium vivax</i> malariaMimi M Hou, Jordan R Barrett, Yrene Themistocleous, et al.
Nature Communications|September 25, 2025
Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infectionMimi M Hou, Adam C Harding, Natalie M Barber, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Medicine (London, England)|November 3, 2024
Malaria: Past, present and futureJo Salkeld, Andrew Duncan, Angela M Minassian
Clinical Infection in Practice|August 24, 2021
Compassionate use of REGN-COV2 in the treatment of COVID-19 in a patient with impaired humoral immunityHanna Nguyen, Jo Salkeld, Sangita Agarwal, et al.
Clinical Infection in Practice|June 26, 2023
Prescribing in a pandemic: Electronic prescribing aids to improve non-specialist adherence to COVID-19 guidelinesMarc Woodman, Jo Salkeld, Connor Sharrock, et al.
Geriatrics (Basel, Switzerland)|July 8, 2020
Inter-Relationships between Frailty, Sarcopenia, Undernutrition and Dysphagia in Older People Who Are Admitted to Acute Frailty and Medical Wards: Is There an Older Adult Quartet?David Smithard, Dharinee Hansjee, Darrien Henry, et al.
Frontiers in Immunology|September 8, 2022
Repeat controlled human malaria infection of healthy UK adults with blood-stage <i>Plasmodium falciparum</i>: Safety and parasite growth dynamicsJo Salkeld, Yrene Themistocleous, Jordan R Barrett, et al.
Immunity|June 12, 2026
Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protectionBarnabas G Williams, Jordan R Barrett, Josefin Bartholdson Scott, et al.
The Lancet. Infectious Diseases|December 13, 2024
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in childrenHamtandi M Natama, Jo Salkeld, Athanase Somé, et al.
Science Translational Medicine|July 12, 2023
Vaccination with <i>Plasmodium vivax</i> Duffy-binding protein inhibits parasite growth during controlled human malaria infectionMimi M Hou, Jordan R Barrett, Yrene Themistocleous, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2022
Impact of a blood-stage vaccine on <i>Plasmodium vivax</i> malariaMimi M Hou, Jordan R Barrett, Yrene Themistocleous, et al.
Nature Communications|September 25, 2025
Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infectionMimi M Hou, Adam C Harding, Natalie M Barber, et al.
Pageof 2